CA2687118A1 - Methods of using low-dose doxepin for the improvement of sleep - Google Patents

Methods of using low-dose doxepin for the improvement of sleep Download PDF

Info

Publication number
CA2687118A1
CA2687118A1 CA002687118A CA2687118A CA2687118A1 CA 2687118 A1 CA2687118 A1 CA 2687118A1 CA 002687118 A CA002687118 A CA 002687118A CA 2687118 A CA2687118 A CA 2687118A CA 2687118 A1 CA2687118 A1 CA 2687118A1
Authority
CA
Canada
Prior art keywords
doxepin
sleep
period
dosage
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA002687118A
Other languages
English (en)
French (fr)
Inventor
Roberta L. Rogowski
Susan E. Dube
Philip Jochelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Currax Pharmaceuticals LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38801962&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2687118(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2687118A1 publication Critical patent/CA2687118A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CA002687118A 2006-05-19 2007-05-18 Methods of using low-dose doxepin for the improvement of sleep Pending CA2687118A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US80182406P 2006-05-19 2006-05-19
US60/801,824 2006-05-19
US83331906P 2006-07-25 2006-07-25
US60/833,319 2006-07-25
PCT/US2007/012105 WO2007142810A2 (en) 2006-05-19 2007-05-18 Methods of using low-dose doxepin for the improvement of sleep

Publications (1)

Publication Number Publication Date
CA2687118A1 true CA2687118A1 (en) 2007-12-13

Family

ID=38801962

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002687118A Pending CA2687118A1 (en) 2006-05-19 2007-05-18 Methods of using low-dose doxepin for the improvement of sleep

Country Status (4)

Country Link
US (9) US8513299B2 (enExample)
JP (4) JP2009537553A (enExample)
CA (1) CA2687118A1 (enExample)
WO (1) WO2007142810A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2687118A1 (en) 2006-05-19 2007-12-13 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
US20100179215A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
WO2007136845A2 (en) * 2006-05-19 2007-11-29 Somaxon Pharmaceuticals, Inc. Low-dose doxepin for treatment of sleep disorders in elderly patients
US20100227916A1 (en) * 2006-05-19 2010-09-09 Somaxon Pharmaceuticals, Inc N-desmethyl-doxepin and methods of using the same to treat sleep disorders
US20100179214A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
CA2693992C (en) * 2006-07-20 2017-01-31 Somaxon Pharmaceuticals, Inc. Methods of improving the pharmacokinetics of doxepin
US20080182890A1 (en) * 2006-10-04 2008-07-31 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
WO2008052139A2 (en) * 2006-10-25 2008-05-02 Somaxon Pharmaceuticals, Inc. Ultra low dose doxepin and methods of using the same to treat sleep disorders
WO2008070795A2 (en) * 2006-12-06 2008-06-12 Somaxon Pharmaceuticals, Inc. Combination therapy using low-dose doxepin for the improvement of sleep
EP2148659A2 (en) 2007-04-13 2010-02-03 Somaxon Pharmaceuticals, Inc. Low-dose doxepin formulations
WO2014145045A1 (en) * 2013-03-15 2014-09-18 Tonix Pharmaceuticals, Inc. Compositions and methods for transmucosal absorption
US9562030B2 (en) 2013-03-19 2017-02-07 Council Of Scientific And Industrial Research Process for the synthesis of olopatadine
WO2020185712A1 (en) * 2019-03-08 2020-09-17 Alairion, Inc. Methods for treating sleep fragmentation disorders

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3420851A (en) 1962-12-19 1969-01-07 Pfizer & Co C Novel dibenzoxepines
FR88751E (enExample) 1963-07-09 1967-06-07
US3509175A (en) 1963-10-14 1970-04-28 Pfizer & Co C Recovery of pure cis 11-(3-dimethylaminopropylidene) - 6,11 - dihydrodibenz(b,e)oxepine from admixture with its trans isomer
US4110438A (en) 1977-03-21 1978-08-29 American Home Products Corporation Method of treating depression
CH646696A5 (de) 1980-11-28 1984-12-14 Sandoz Ag Dibenzazepine, ihre herstellung und verwendung.
US5030632A (en) 1986-09-23 1991-07-09 Sandoz Pharm. Corp. Low dose temazepam
US4833154A (en) 1987-12-14 1989-05-23 Jean Louis Louis J Natural sleeping pill to prevent and alleviate insomnia
US5116852A (en) 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders
US5332661A (en) 1991-07-31 1994-07-26 Abbott Laboratories Reagents and methods for the quantification of total doxepins in biological fluids
US5502047A (en) 1993-03-22 1996-03-26 Kavey; Neil B. Treatment for insomnia
US6936277B2 (en) 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
IL116674A (en) 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5948438A (en) 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US6106865A (en) 1995-01-09 2000-08-22 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US6471994B1 (en) 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US6395303B1 (en) 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US5585115A (en) 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6852336B2 (en) 1995-11-15 2005-02-08 J. Rettenmaier & Soehne Gmbh + Co. Kg Directly compressible high load acetaminophen formulations
US6391337B2 (en) 1995-11-15 2002-05-21 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US5733578A (en) 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
AU2406299A (en) 1998-02-12 1999-08-30 Centrapharm Inc. Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect
JP2003520189A (ja) 1998-08-25 2003-07-02 セプラコア インコーポレーテッド 光学的に純粋なｓ（＋）ビガバトリンを用いる方法および組成物
GB9904163D0 (en) 1999-02-23 1999-04-14 Bioglan Lab Ltd Pharmaceutical compositions
ES2212737B1 (es) * 1999-08-13 2005-10-01 Vela Pharmaceuticals Inc. Ciclobenzaprina para tratar trastornos de ansiedad generalizada y composiciones de la misma.
US6219674B1 (en) 1999-11-24 2001-04-17 Classen Immunotherapies, Inc. System for creating and managing proprietary product data
BR0015994A (pt) 1999-11-30 2002-08-06 Panacea Biotec Ltd Composição de dissolução rápida com sabor doce prolongado
US6211229B1 (en) * 2000-02-17 2001-04-03 Neil B. Kavey Treatment of transient and short term insomnia
US6344487B1 (en) 2000-06-05 2002-02-05 Neil B. Kavey Treatment of insomnia
US7135196B2 (en) 2000-09-19 2006-11-14 Vitra Pharmaceuticals Limited Iron compositions
AU2587002A (en) 2000-11-03 2002-05-15 Biomedicines Inc Method for short-term and long-term drug dosimetry
US20020122078A1 (en) * 2000-12-07 2002-09-05 Markowski Michael J. System and method for organizing, navigating and analyzing data
WO2002069974A1 (en) * 2001-03-05 2002-09-12 Andrew Holman Administration of sleep restorative agents
WO2003004009A1 (en) 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Pharmaceutical composition
US7179488B2 (en) 2001-11-29 2007-02-20 Bob Sherwood Process for co-spray drying liquid herbal extracts with dry silicified MCC
US20030206978A1 (en) 2001-11-29 2003-11-06 Bob Sherwood Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6407128B1 (en) 2001-12-03 2002-06-18 Elan Pharmaceuticals, Inc. Method for increasing the bioavailability of metaxalone
PL372290A1 (en) 2002-02-07 2005-07-11 Pharmacia Corporation Pharmaceutical dosage form for mucosal delivery
UA81423C2 (en) 2002-08-15 2008-01-10 PRODUCT CONTAINING SRI AND AGONIST OF THE 5HT2a RECEPTOR FOR TREATMENT OF THERMOREGULATORY DYSFUNCTION
US20040115142A1 (en) 2002-09-05 2004-06-17 Jrs Pharma Lp Compositions for industrial applications
US20040097488A1 (en) * 2002-11-14 2004-05-20 Bernstein Joel E. Compositions and method for treating affective, painful or allergic disorders
BRPI0408323A (pt) 2003-03-14 2006-03-07 Nirmal Mulye processo para a preparação de compimidos de liberação prolongada
JP2006520810A (ja) 2003-03-17 2006-09-14 日本たばこ産業株式会社 Ｓ−［２−（［［１−（２−エチルブチル）シクロヘキシル］カルボニル］アミノ）フェニル］２−メチルプロパンチオエートの経口吸収性を増加させる方法
US20050118261A1 (en) 2003-06-12 2005-06-02 Oien Hal J. Compositions and methods of administering doxepin to mucosal tissue
US20050196439A1 (en) 2003-10-24 2005-09-08 J. Rettenmaier & Soehne Gmbh + Co. Kg Process for co-spray drying agents with dry silicified MCC
US7326721B2 (en) 2003-12-10 2008-02-05 Hypnion, Inc. Doxepin analogs and methods of use thereof
US7482460B2 (en) 2003-12-10 2009-01-27 Hypnion, Inc. Doxepin analogs and methods of use thereof
EP2343073A3 (en) 2003-12-11 2011-10-12 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
US20050214365A1 (en) 2004-03-24 2005-09-29 Gulf Pharmaceutical Industries [Instant dissolving tablet composition for loratidine and desloratidine]
WO2005102335A2 (en) 2004-04-23 2005-11-03 Hypnion, Inc. Methods of treating sleep disorders
US20060228487A1 (en) 2005-04-11 2006-10-12 J. Rettenmaier & Söehne GmbH + Co. KG Methods of combining active agents with augmented microcrystalline cellulose
US7452872B2 (en) 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
CA2687118A1 (en) 2006-05-19 2007-12-13 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
US20090042972A1 (en) 2006-05-19 2009-02-12 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
US20100179215A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
US20100227916A1 (en) 2006-05-19 2010-09-09 Somaxon Pharmaceuticals, Inc N-desmethyl-doxepin and methods of using the same to treat sleep disorders
WO2007136845A2 (en) 2006-05-19 2007-11-29 Somaxon Pharmaceuticals, Inc. Low-dose doxepin for treatment of sleep disorders in elderly patients
US20100179214A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
CA2687124A1 (en) 2006-05-19 2007-12-13 Somaxon Pharmaceuticals, Inc. Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia
US20090042971A1 (en) 2006-05-19 2009-02-12 Somaxon Pharmaceuticals, Inc. Method of using low-dose doxepin for the improvement of sleep
CA2693992C (en) 2006-07-20 2017-01-31 Somaxon Pharmaceuticals, Inc. Methods of improving the pharmacokinetics of doxepin
US20080182890A1 (en) 2006-10-04 2008-07-31 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
WO2008052139A2 (en) 2006-10-25 2008-05-02 Somaxon Pharmaceuticals, Inc. Ultra low dose doxepin and methods of using the same to treat sleep disorders
WO2008070795A2 (en) 2006-12-06 2008-06-12 Somaxon Pharmaceuticals, Inc. Combination therapy using low-dose doxepin for the improvement of sleep
EP2148659A2 (en) 2007-04-13 2010-02-03 Somaxon Pharmaceuticals, Inc. Low-dose doxepin formulations

Also Published As

Publication number Publication date
US20190216766A1 (en) 2019-07-18
US9486437B2 (en) 2016-11-08
US12083090B2 (en) 2024-09-10
US20180125809A1 (en) 2018-05-10
US8513299B2 (en) 2013-08-20
US10653662B2 (en) 2020-05-19
US20200345680A1 (en) 2020-11-05
US20250268858A1 (en) 2025-08-28
US9107898B2 (en) 2015-08-18
US20070281990A1 (en) 2007-12-06
US20170049743A1 (en) 2017-02-23
US20110178166A1 (en) 2011-07-21
JP2013237694A (ja) 2013-11-28
JP2016041757A (ja) 2016-03-31
US20150320717A1 (en) 2015-11-12
US20120245222A1 (en) 2012-09-27
JP2018044006A (ja) 2018-03-22
WO2007142810A3 (en) 2008-03-13
US9861607B2 (en) 2018-01-09
JP2009537553A (ja) 2009-10-29
US10238620B2 (en) 2019-03-26
WO2007142810A2 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
US20250268858A1 (en) Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep
US20090042971A1 (en) Method of using low-dose doxepin for the improvement of sleep
US20090042972A1 (en) Methods of using low-dose doxepin for the improvement of sleep
US10758510B2 (en) Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
US20220151975A1 (en) Low-Dose Doxepin For Treatment Of Sleep Disorders In Elderly Patients
US11007168B2 (en) Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
US9907779B2 (en) Ultra low dose doxepin and methods of using the same to treat sleep disorders
US20130150434A1 (en) Methods of using low-dose doxepin for the improvement of sleep
US20100227916A1 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
WO2009137531A2 (en) Compositions and methods related to action of low dosages of doxepin on the h1 and 5-ht2a receptors
WO2007136743A2 (en) Dothiepin and methods of using the same to treat sleep disorders

Legal Events

Date Code Title Description
EEER Examination request
EEER Examination request

Effective date: 20120507

EEER Examination request

Effective date: 20120507

EEER Examination request

Effective date: 20120507